Drug Profile
Research programme: beta lactamase inhibitors - Wockhardt
Alternative Names: WCK 4234Latest Information Update: 28 Jul 2020
Price :
$50
*
At a glance
- Originator Wockhardt
- Class Antibacterials
- Mechanism of Action Beta lactamase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 28 Jul 2020 No recent reports of development identified for research development in Bacterial-infections in India
- 16 Jun 2016 Early research in Bacterial infections in India (unspecified route) before June 2016
- 16 Jun 2016 Pharmacokinetics and antimicrobial activity data from an in vitro study in Bacterial infections released by Wockhardt